I agree that this site is using cookies. You can find further informations here.
X
Wateska, Angela R.
77  results:
Search for persons X
?
1

Corrigendum to "Cost-effectiveness of an in-development adu..:

Altawalbeh, Shoroq M. ; Wateska, Angela R. ; Patricia Nowalk, Mary...
Vaccine.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pneumococcal Vaccination Strategies in 50-Year-Olds to Decr..:

Altawalbeh, Shoroq M. ; Wateska, Angela R. ; Nowalk, Mary Patricia...
Value in Health.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Cost-effectiveness of an in-development adult-formulated 21..:

Altawalbeh, Shoroq M. ; Wateska, Angela R. ; Nowalk, Mary Patricia...
Vaccine.  42 (2024)  12 - p. 3024-3032 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Changes in the cost‐effectiveness of pneumococcal vaccinati..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Altawalbeh, Shoroq M....
Journal of the American Geriatrics Society.  , 2024
Link: https://doi.org/10.1111/..
 
?
5

Societal Cost of Racial Pneumococcal Disease Disparities in..:

Altawalbeh, Shoroq M. ; Wateska, Angela R. ; Nowalk, Mary Patricia...
Applied Health Economics and Health Policy.  , 2023
Link: https://doi.org/10.1007/..
 
?
6

Cost-effectiveness of an in-development adult-formulated pn..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Lin, Chyongchiou J....
Vaccine.  41 (2023)  30 - p. 4431-4437 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Cost-Effectiveness of Newly Recommended Pneumococcal Vaccin..:

Smith, Kenneth J. ; Wateska, Angela R. ; Nowalk, Mary Patricia...
Infectious Diseases and Therapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
8

Cost-effectiveness of revised US pneumococcal vaccination r..:

Wateska, Angela R. ; Patricia Nowalk, Mary ; Lin, Chyongchiou J....
Vaccine.  40 (2022)  50 - p. 7312-7320 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Higher-Valency Pneumococcal Conjugate Vaccines: An Explorat..:

Smith, Kenneth J. ; Wateska, Angela R. ; Nowalk, Mary Patricia...
American Journal of Preventive Medicine.  61 (2021)  1 - p. 28-36 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Is further research on adult pneumococcal vaccine uptake im..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Jalal, Hawre...
Vaccine.  39 (2021)  27 - p. 3608-3613 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Should older adult pneumococcal vaccination recommendations..:

Smith, Kenneth J. ; Wateska, Angela R. ; Nowalk, Mary Patricia...
Vaccine.  39 (2021)  31 - p. 4278-4282 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Cost-Effectiveness of Pneumococcal Vaccination and Uptake I..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Lin, Chyongchiou J....
Journal of Community Health.  45 (2020)  1 - p. 111-120 , 2020
Link: https://www.jstor.org/st..
 
?
13

Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Eff..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Lin, Chyongchiou J....
American Journal of Preventive Medicine.  58 (2020)  4 - p. 487-495 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Cost‐Effectiveness of Pneumococcal Vaccination Policies and..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Lin, Chyongchiou J....
Journal of the American Geriatrics Society.  68 (2020)  6 - p. 1271-1278 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Cost-effectiveness of adult pneumococcal vaccination polici..:

Wateska, Angela R. ; Nowalk, Mary Patricia ; Lin, Chyongchiou J....
Vaccine.  37 (2019)  14 - p. 2026-2033 , 2019
Link: https://doi.org/10.1016/..
 
1-15